A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sodium lauryl sulfate
Vildagliptin
The risk or severity of angioedema can be increased when Captopril is combined with Vildagliptin.
Sodium lauryl sulfate
Spirapril
The risk or severity of angioedema can be increased when Captopril is combined with Spirapril.
Sodium lauryl sulfate
Cilazapril
The risk or severity of angioedema can be increased when Captopril is combined with Cilazapril.
Sodium lauryl sulfate
Rescinnamine
The risk or severity of angioedema can be increased when Rescinnamine is combined with Captopril.
Sodium lauryl sulfate
Omapatrilat
The risk or severity of angioedema can be increased when Omapatrilat is combined with Captopril.
Sodium lauryl sulfate
Ubidecarenone
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Ubidecarenone.
Sodium lauryl sulfate
Pitavastatin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Pitavastatin.
Sodium lauryl sulfate
Colchicine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Colchicine.
Sodium lauryl sulfate
Docetaxel
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Docetaxel.
Sodium lauryl sulfate
Dexamethasone
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Dexamethasone.
Sodium lauryl sulfate
Metoclopramide
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Metoclopramide.
Sodium lauryl sulfate
Saquinavir
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Saquinavir.
Sodium lauryl sulfate
Paclitaxel
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Paclitaxel is combined with Captopril.
Sodium lauryl sulfate
Fusidic acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Fusidic acid.
Sodium lauryl sulfate
Isoniazid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Captopril.
Sodium lauryl sulfate
Fenofibric acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Fenofibric acid.
Sodium lauryl sulfate
Clofibride
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Clofibride.
Sodium lauryl sulfate
Aluminium clofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Aluminium clofibrate.
Sodium lauryl sulfate
Ronifibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Ronifibrate.
Sodium lauryl sulfate
Simfibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Simfibrate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3